Richardsen E - Search Results

1

Low Expression of miR-424-3p is Highly Correlated with Clinical Failure in Prostate Cancer.

Richardsen E, Andersen S, Al-Saad S, Rakaee M, Nordby Y, Pedersen MI, Ness N, Ingebriktsen LM, Fassina A, Taskén KA, Mills IG, Donnem T, Bremnes RM, Busund LT. Richardsen E, et al. Sci Rep. 2019 Jul 23;9(1):10662. doi: 10.1038/s41598-019-47234-0. Sci Rep. 2019. PMID: 31337863 Free PMC article.

2

Significant expression of IGFBP2 in breast cancer compared with benign lesions.

Busund LT, Richardsen E, Busund R, Ukkonen T, Bjørnsen T, Busch C, Stalsberg H. Busund LT, et al. Among authors: richardsen e. J Clin Pathol. 2005 Apr;58(4):361-6. doi: 10.1136/jcp.2004.020834. J Clin Pathol. 2005. PMID: 15790698 Free PMC article.

3

The prognostic impact of M-CSF, CSF-1 receptor, CD68 and CD3 in prostatic carcinoma.

Richardsen E, Uglehus RD, Due J, Busch C, Busund LT. Richardsen E, et al. Histopathology. 2008 Jul;53(1):30-8. doi: 10.1111/j.1365-2559.2008.03058.x. Epub 2008 May 28. Histopathology. 2008. PMID: 18510570

4

Expression of M-CSF and CSF-1R is correlated with histological grade in soft tissue tumors.

Richardsen E, Sørbye SW, Crowe JP, Yang JL, Busund LT. Richardsen E, et al. Anticancer Res. 2009 Oct;29(10):3861-6. Anticancer Res. 2009. PMID: 19846920 Free article.

5

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67.

Richardsen E, Uglehus RD, Due J, Busch C, Busund LT. Richardsen E, et al. Cancer Epidemiol. 2010 Jun;34(3):316-22. doi: 10.1016/j.canep.2010.03.019. Epub 2010 Apr 22. Cancer Epidemiol. 2010. PMID: 20409773

6

Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer.

Richardsen E, Uglehus RD, Johnsen SH, Busund LT. Richardsen E, et al. BMC Res Notes. 2012 Feb 21;5:110. doi: 10.1186/1756-0500-5-110. BMC Res Notes. 2012. PMID: 22353218 Free PMC article.

7

Positive prognostic impact of miR-210 in non-small cell lung cancer.

Eilertsen M, Andersen S, Al-Saad S, Richardsen E, Stenvold H, Hald SM, Al-Shibli K, Donnem T, Busund LT, Bremnes RM. Eilertsen M, et al. Among authors: richardsen e. Lung Cancer. 2014 Feb;83(2):272-8. doi: 10.1016/j.lungcan.2013.11.005. Epub 2013 Nov 14. Lung Cancer. 2014. PMID: 24305009

8

Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time.

Andersen S, Richardsen E, Nordby Y, Ness N, Størkersen O, Al-Shibli K, Donnem T, Bertilsson H, Busund LT, Angelsen A, Bremnes RM. Andersen S, et al. Among authors: richardsen e. BMC Urol. 2014 Jun 14;14:49. doi: 10.1186/1471-2490-14-49. BMC Urol. 2014. PMID: 24929427 Free PMC article.

9

Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer.

Ness N, Andersen S, Valkov A, Nordby Y, Donnem T, Al-Saad S, Busund LT, Bremnes RM, Richardsen E. Ness N, et al. Among authors: richardsen e. Prostate. 2014 Oct;74(14):1452-61. doi: 10.1002/pros.22862. Epub 2014 Aug 11. Prostate. 2014. PMID: 25111810

10

Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival.

Eilertsen M, Andersen S, Al-Saad S, Kiselev Y, Donnem T, Stenvold H, Pettersen I, Al-Shibli K, Richardsen E, Busund LT, Bremnes RM. Eilertsen M, et al. Among authors: richardsen e. PLoS One. 2014 Sep 16;9(9):e105038. doi: 10.1371/journal.pone.0105038. eCollection 2014. PLoS One. 2014. PMID: 25225794 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters